Your browser doesn't support javascript.
loading
A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older Adults.
Nussbaum, Jesse; Hussain, Azher; Ford, Anthony; Butera, Peter; Kitt, Michael; Smith, Steve; Stoch, Aubrey; Iwamoto, Marian.
  • Nussbaum J; Merck & Co., Inc., Rahway, NJ, USA. jesse.nussbaum@merck.com.
  • Hussain A; , 213 E Grand Ave, South San Francisco, CA, 94080, USA. jesse.nussbaum@merck.com.
  • Ford A; Merck & Co., Inc., Rahway, NJ, USA.
  • Butera P; Merck & Co., Inc., Rahway, NJ, USA.
  • Kitt M; Merck & Co., Inc., Rahway, NJ, USA.
  • Smith S; Merck & Co., Inc., Rahway, NJ, USA.
  • Stoch A; Merck & Co., Inc., Rahway, NJ, USA.
  • Iwamoto M; Merck & Co., Inc., Rahway, NJ, USA.
Lung ; 200(3): 315-323, 2022 06.
Article en En | MEDLINE | ID: mdl-35670873
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Tos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Tos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article